Medicis Pharmaceutical, located in Scottsdale, Arizona, is paying $9.8 million to settle False Claims Act allegations.  This case was brought by four former Medicis sales representatives. The allegations centered around Loprox, a topical skin preparation.  Loprox, while approved by the FDA as a fungicide for patients over 10 years of age, was off-label marketed for the treatment of diaper rash.  This marketing or promoting for unapproved uses by Medicis Pharmaceutical is prohibited.

To read more about this case, click here or  to read more on filing qui tam actions go to Nolan & Auerbach.